Lixte Biotechnology Holdings, Inc.
NASDAQLixte Biotechnology Holdings heads into its May 15 earnings report on the back of a 72% price surge over the past month — and with insiders who evidently share the enthusiasm. The most striking element of the pre-earnings setup is the insider activity. The CEO and Chairman, Geordan Pursglove, received an award of 350,000 shares at $2.83 on April 15 — a stake worth roughly $990,500…
LIXT short interest plummeted 25.8% in one day to 0.96% of float, after surging 39.1% over the past week. The biotech stock reports earnings tomorrow.
Snapshot as of 15 May 2026
Lixte Biotechnology Holdings heads into its May 15 earnings report on the back of a 72% price surge over the past month — and with insiders who evidently share the enthusiasm. The most striking element of the…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for LIXT — free to start on ORTEX.
Sign up for free →Open LIXT on ORTEXPulses are triggered by ORTEX's live data feeds. The full signal history, thresholds, and alerts are on ORTEX.
Live LIXT data →